← FDA Drug Approvals (Drugs@FDA)

BUPRENORPHINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2025-01-30

Drug application

FDA Application #
ANDA219302
Application type
Abbreviated New Drug Application (Generic)
Brand name
BUPRENORPHINE HYDROCHLORIDE
Generic name
BUPRENORPHINE HYDROCHLORIDE
Active ingredients
BUPRENORPHINE HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
SOMERSET THERAPS LLC
Manufacturer
Somerset Therapeutics, LLC
First approval
2025-01-30

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown